These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 2535299

  • 1. The phosphodiesterase-inhibitor enoximone--a new concept in the therapy of patients with impaired myocardial function in cardiac surgery.
    Boldt J, Kling D, Hempelmann G.
    J Cardiothorac Anesth; 1989 Oct; 3(5 Suppl 1):10. PubMed ID: 2535299
    [No Abstract] [Full Text] [Related]

  • 2. [Hemodynamic effects of enoximone--comparative studies of heart surgery patients].
    Boldt J, Hempelmann G.
    Z Kardiol; 1991 Oct; 80 Suppl 4():41-6. PubMed ID: 1833896
    [Abstract] [Full Text] [Related]

  • 3. Influence of phosphodiesterase inhibition on myocardial energetics in dilative cardiomyopathy.
    Hasenfuss G, Holubarsch C, Heiss WH, Bonzel T, Meinertz T, Just H.
    Basic Res Cardiol; 1987 Oct; 82 Suppl 2():403-9. PubMed ID: 2959265
    [Abstract] [Full Text] [Related]

  • 4. [Vasodilatation and positive inotropic effect of the phosphodiesterase inhibitor enoximone].
    Holubarsch C, Hasenfuss G, Thierfelder L, Heiss HW, Just H.
    Z Kardiol; 1991 Oct; 80 Suppl 4():35-40. PubMed ID: 1833895
    [Abstract] [Full Text] [Related]

  • 5. Beneficial haemodynamic effects of enoximone in cardiac transplant candidates awaiting a suitable donor.
    Vulser C, Guillemain R, Amrein C, Trinquier R, Farge D, Dreyfus G, Couetil JP, Carpentier A, Cousin MT.
    J Cardiothorac Anesth; 1989 Oct; 3(5 Suppl 1):11. PubMed ID: 2535300
    [No Abstract] [Full Text] [Related]

  • 6. [Use of a new inotropic agent, enoximone, in heart surgery].
    Gomar C, Fita G, Pomar JL, Valero R, Mulet J, Nalda MA.
    Rev Esp Anestesiol Reanim; 1991 Oct; 38(2):121-6. PubMed ID: 1678896
    [Abstract] [Full Text] [Related]

  • 7. [The effect of enoximone and catecholamines on renal function after open heart surgery].
    Zeplin HE.
    Z Kardiol; 1991 Oct; 80 Suppl 4():59-62. PubMed ID: 1833899
    [No Abstract] [Full Text] [Related]

  • 8. Augmentation of diastolic function with phosphodiesterase inhibition in congestive heart failure.
    Binkley PF, Shaffer PB, Ryan JM, Leier CV.
    J Lab Clin Med; 1989 Sep; 114(3):266-71. PubMed ID: 2527935
    [Abstract] [Full Text] [Related]

  • 9. Comparison of cardiovascular effects of dobutamine and enoximone in treatment of low cardiac output syndrome after valvular surgery--preliminary results.
    George M, Lehot JJ, Bastien O, Durand PG, Estanove S.
    J Cardiothorac Anesth; 1989 Oct; 3(5 Suppl 1):12. PubMed ID: 2535301
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparison between the positive inotropic effects of enoximone, a cardiac phosphodiesterase III inhibitor, and dobutamine in patients with moderate to severe congestive heart failure. A study using the end-systolic pressure-volume relationship method.
    Installe E, De Coster P, Gonzalez M, Brichant C, Lessire H, Cauwe F.
    Eur Heart J; 1991 Sep; 12(9):985-93. PubMed ID: 1834466
    [Abstract] [Full Text] [Related]

  • 12. Comparison of dobutamine and enoximone for low output states following cardiac surgery.
    Orellano L, Darwisch M, Dieterich HA, Köllner V.
    Int J Cardiol; 1990 Jul; 28 Suppl 1():S13-9. PubMed ID: 2145233
    [Abstract] [Full Text] [Related]

  • 13. [Comparison of new cardiac agents using differential therapeutic criteria].
    Redmann K, Lunkenheimer PP, Rettig G, Isringhaus H, Flameng W, Demeyere R.
    Z Kardiol; 1991 Jul; 80 Suppl 4():7-14. PubMed ID: 1833902
    [Abstract] [Full Text] [Related]

  • 14. Management of low cardiac output syndrome after cardiac surgery using enoximone.
    White DA, Latimer RD, Oduro A.
    Anaesthesia; 1990 May; 45(5):386-9. PubMed ID: 2141451
    [Abstract] [Full Text] [Related]

  • 15. Treatment of heart failure with enoximone, a new phosphodiesterase inhibitor. Düsseldorf, Federal Republic of Germany. September 25-27, 1987. Proceedings.
    J Cardiovasc Pharmacol; 1989 May; 14 Suppl 1():S1-S83. PubMed ID: 2480479
    [No Abstract] [Full Text] [Related]

  • 16. Comparison of enoximone and piroximone in patients after mitral valve operation: a prospective and controlled clinical study.
    Hausen B, Heublein B, Vogelpohl J, von der Leyen H, Haverich A.
    J Cardiovasc Pharmacol; 1992 Mar; 19(3):299-307. PubMed ID: 1378106
    [Abstract] [Full Text] [Related]

  • 17. [Comparison of the hemodynamic effect of enoximone and dopamine in patients after coronary bypass operation].
    Birnbaum DE, Preuner JG, Gieseke R, Kasper-König W, Trenk D, Jähnchen E, Dieterich HA.
    Z Kardiol; 1991 Mar; 80 Suppl 4():47-52. PubMed ID: 1833897
    [Abstract] [Full Text] [Related]

  • 18. Enoximone.
    Lancet; 1988 May 14; 1(8594):1085-6. PubMed ID: 2896916
    [No Abstract] [Full Text] [Related]

  • 19. Peripheral and cardiac effects of a new phosphodiesterase inhibitor in comparison with enoximone.
    Schröder T, Hering JP, Foth H, Ferrari M, Sipinková I, Hellige G.
    Arzneimittelforschung; 1994 Aug 14; 44(8):948-50. PubMed ID: 7945538
    [Abstract] [Full Text] [Related]

  • 20. Comparative study of the effects of enoximone and dobutamine in patients with impaired left ventricular function undergoing cardiac surgery.
    Keogh B, Priddy R, Morgan C, Gillbe C.
    Cardiology; 1990 Aug 14; 77 Suppl 3():58-61; discussion 62-7. PubMed ID: 2148282
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.